Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936637 · ClinicalTrials.gov registry record · NA
Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term
A NA study of Growth, sponsored by Perrigo Nutritionals.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT00936637: Completed NA study of Growth, sponsored by Perrigo Nutritionals.
NCT00936637 is a NA study of Growth that has completed, run by Perrigo Nutritionals. The registered enrollment target is 35 participants, below the 737-participant average among 3 other Growth trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00936637, a NA study of Growth, has completed, sponsored by Perrigo Nutritionals.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.
Conditions Studied
Interventions
- OTHER Extensively hydrolyzed infant formula
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00936637 record still lists
NCT00936637 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 737-participant average among 3 other Growth trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Growth appearing as the primary indexed condition, and to 1 intervention - of which Extensively hydrolyzed infant formula is the first listed.
NCT00936637 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT00936637 about?
NCT00936637 is a clinical study titled "Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term". The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.
What is the current status of trial NCT00936637?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2007-07. Estimated completion is 2008-12.
What conditions does trial NCT00936637 study?
This clinical trial studies the following conditions: Growth.
What interventions are being tested in trial NCT00936637?
The interventions under investigation include: Extensively hydrolyzed infant formula (OTHER).
Who is sponsoring clinical trial NCT00936637?
This trial is sponsored by Perrigo Nutritionals, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00936637 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia